Article Information
History
- January 8, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- David M Kent, MD, MS1,*,
- Jason Nelson, MPH1,
- Anastassios Pittas, MD, MS2,
- Francis Colangelo, MD, MS3,
- Carolyn Koenig, MD4,
- David van Klaveren, PhD1,5,
- Elizabeth Ciemins, PhD6 and
- John Cuddeback, MD, PhD6
- 1Predictive Analytics and Comparative Effectiveness Center, Tufts Medical Center, Boston, MA
- 2Division of Endocrinology, Tufts Medical Center, Boston, MA
- 3Allegheny Health Network, Pittsburgh, PA
- 4Mercy Health, St. Louis, MO
- 5Department of Public Health, Erasmus MC University Medical Center, Rotterdam, the Netherlands
- 6AMGA (American Medical Group Association), Alexandria, VA
- ↵*Corresponding Author:
David Kent, MD, MS, Director, Predictive Analytics and Comparative Effectiveness (PACE) Center, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, 800 Washington St, Box 63 Boston, MA 02111, dkent1{at}tuftsmedicalcenter.org
Posted January 08, 2021.
An Electronic Health Record Compatible Model to Predict Personalized Treatment Effects from the Diabetes Prevention Program: A Cross-Evidence Synthesis Approach Using Clinical Trial and Real World Data
